Takeda Pharmaceutical (TAK) EPS (Weighted Average and Diluted) Growth (1y) (2018 - 2026)
Takeda Pharmaceutical (TAK) EPS (Weighted Average and Diluted) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 72.22% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 5.97% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -12.22% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -94.22% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 2,287.50% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -15.38% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -407.69% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 76.47% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -300.00% |
| 10 | Takeda Pharmaceutical | 169,771.34 | -6.60 Bn | 4.39 Bn | -104.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -104.94% |
| Dec 31, 2025 | 21.04% |
| Sep 30, 2025 | 66.23% |
| Jun 30, 2025 | 70.78% |
| Mar 31, 2025 | 12,536.21% |
| Dec 31, 2024 | -49.69% |
| Sep 30, 2024 | -39.77% |
| Jun 30, 2024 | 1.53% |
| Mar 31, 2024 | -102.86% |
| Dec 31, 2023 | 161.99% |
| Sep 30, 2023 | 1,615.27% |
| Jun 30, 2023 | 0.69% |
| Mar 31, 2023 | 1,584.37% |
| Dec 31, 2022 | 72.77% |
| Sep 30, 2022 | 46.29% |
| Jun 30, 2022 | -1.27% |
| Mar 31, 2022 | -109.44% |
| Dec 31, 2021 | -53.52% |
| Sep 30, 2021 | 439.25% |
| Jun 30, 2021 | 0.54% |